ARVINAS (ARVN) CMO Noah Berkowitz Sells Shares

What Happened
Noah Berkowitz, Chief Medical Officer of Arvinas, sold 6,435 shares on March 18, 2026 at $11.10 per share, generating proceeds of $71,431. The filing indicates this was an automatic sale to satisfy tax withholding tied to the vesting and settlement of 25% of RSUs granted March 18, 2024, and not a discretionary trade.

Key Details

• Transaction date: 2026-03-18; Price: $11.10; Shares sold: 6,435; Proceeds: $71,431. (Transaction code: S = Sale)
• Footnote: The sale was automatic by the issuer to cover tax withholding obligations on vested RSUs (footnote F1); it does not represent a discretionary trade.
• Shares owned after the transaction: not disclosed in this Form 4.
• Filing: Form 4 filed 2026-03-19 (timely; filed within one business day of the transaction).

Context
Automatic withholding sales on RSU vesting are common and are executed to satisfy tax obligations; they are routine and generally not considered a signal of negative insider sentiment. Purchases or voluntary sales by insiders tend to be more informative about their view of the company.